Bookmark
Forward
CRISPR-Cas9 Disruption of Aquaporin 1: An Alternative to Glaucoma Eye Drop Therapy?
Molecular therapy : the journal of the American Society of Gene Therapy 2020 Mar 04Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
András M Komáromy. CRISPR-Cas9 Disruption of Aquaporin 1: An Alternative to Glaucoma Eye Drop Therapy? Molecular therapy : the journal of the American Society of Gene Therapy. 2020 Mar 04;28(3):706-708
Mesh Tags
Substances
PMID: 32078805
View Full Text
